Meeting Details

  • Board Meeting scheduled for Thursday, 12 November 2026
  • Primary agenda: Consideration and approval of Unaudited Standalone and Consolidated Financial Results for the quarter ended 30 September 2026
  • Results will include Limited Review Reports submitted by the Statutory Auditors of the Company
  • Board may consider other business matters with approval of the Chair

Trading Window Closure

  • Trading window for securities of the Company remains closed for all Designated Persons
  • Closure period extends until 48 hours after declaration of financial results
  • Closure includes 14 November 2026 (inclusive)
  • Continuation of previously intimated trading window closure under SEBI (Prohibition of Insider Trading) Regulations, 2015